Dr. Kulasingam is the Division Head of Clinical Biochemistry at University Health Network and an Associate Professor and Member of the Graduate Faculty of the Department of Laboratory Medicine and Pathobiology, University of Toronto. Dr. Kulasingam is also the Co-Director of the University of Toronto’s Post-Doctoral Training Program in Clinical Chemistry.
She completed her undergraduate, graduate and post-graduate education within LMP. Besides her active involvement in teaching, her research interests include using high-throughput “omics” technologies to understand disease pathogenesis, with a particular emphasis on cancer and rheumatic diseases and its application to clinical practice.
My laboratory is focusing on using high-throughput “omics” technologies to understand disease pathogenesis, with a particular emphasis on cancer and rheumatic diseases and its application to clinical practice.
Kulasingam V, Pavlou M and Diamandis, EP. (2010) Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer. Nat Rev Cancer 10:371-8.
Kulasingam V and Diamandis, EP. (2008) Strategies for Discovering Novel Cancer Biomarkers by Utilizing Emerging Technologies. Nat Clin Pract Oncol. 5:588-99.
Kulasingam V and Diamandis EP. (2008) Tissue culture-based breast cancer biomarker discovery platform. Int J Cancer. 123:2007-12.
Kulasingam V, Smith CR, Batruch I, Buckler A, Jeffery DA, Diamandis EP. (2008) “Product Ion-Monitoring” Assay for Prostate-Specific Antigen in Serum Using a Linear Ion-Trap. J Proteome Res. 7: 640-647.
Kulasingam V and Diamandis, EP. (2007) Proteomic analysis of conditioned media from three breast cancer cell lines: A mine for biomarkers and therapeutic targets. Mol Cell Proteomics. 6: 1997-2011.
Honours and Awards
LMP John B. Walter Prize for Course and Curriculum Design and Development, University of Toronto (2022)